- Home
- XOMA vs CCCC Comparison
XOMA vs CCCC Comparison
Compare XOMA & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMA
- CCCC
- Stock Information
- Founded
- XOMA 1981
- CCCC 2015
- Country
- XOMA United States
- CCCC United States
- Employees
- XOMA N/A
- CCCC N/A
- Industry
- XOMA Biotechnology: Pharmaceutical Preparations
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- XOMA Health Care
- CCCC Health Care
- Exchange
- XOMA Nasdaq
- CCCC Nasdaq
- Market Cap
- XOMA 355.6M
- CCCC 396.0M
- IPO Year
- XOMA N/A
- CCCC 2020
- Fundamental
- Price
- XOMA $30.21
- CCCC $4.31
- Analyst Decision
- XOMA Strong Buy
- CCCC Buy
- Analyst Count
- XOMA 2
- CCCC 5
- Target Price
- XOMA $78.50
- CCCC $11.20
- AVG Volume (30 Days)
- XOMA 30.4K
- CCCC 880.8K
- Earning Date
- XOMA 11-07-2024
- CCCC 10-31-2024
- Dividend Yield
- XOMA N/A
- CCCC N/A
- EPS Growth
- XOMA N/A
- CCCC N/A
- EPS
- XOMA N/A
- CCCC N/A
- Revenue
- XOMA $21,606,000.00
- CCCC $33,668,000.00
- Revenue This Year
- XOMA $488.61
- CCCC $76.74
- Revenue Next Year
- XOMA $27.42
- CCCC N/A
- P/E Ratio
- XOMA N/A
- CCCC N/A
- Revenue Growth
- XOMA 389.82
- CCCC 65.45
- 52 Week Low
- XOMA $14.33
- CCCC $1.06
- 52 Week High
- XOMA $33.78
- CCCC $11.88
- Technical
- Relative Strength Index (RSI)
- XOMA 52.03
- CCCC 30.10
- Support Level
- XOMA $29.09
- CCCC $5.41
- Resistance Level
- XOMA $32.50
- CCCC $6.20
- Average True Range (ATR)
- XOMA 1.87
- CCCC 0.50
- MACD
- XOMA -0.17
- CCCC -0.16
- Stochastic Oscillator
- XOMA 49.29
- CCCC 2.64
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.